The pathophysiological relationships of a myocardial depressant factor (MDF) present in the plasma of cats in hemorrhagic shock were studied. Aprotinin (Trasylol), an inhibitor of a variety of proteases including kallikrein and trypsin, prolonged survival of cats in postoligemic shock as well as prevented the appearance of MDF in the plasma. Trasylol did not alter the arterial blood pressure, venous pressure, or heart rate of these cats in shock, nor did it protect by exerting a positive inotropic effect. Trasylol was ineffective in preventing or reversing the negative inotropic effects of MDF in isolated cat papillary muscles. Column chromatography of plasma from control cats, from untreated shocked cats and from cats treated with Trasylol before shock showed six peptide peaks, designated A, B, C, D, E, and F in decreasing order of molecular weights. Peptides corresponding to peaks A, B, E, and F exhibited insignificant myocardial depressant activity. The peptide corresponding to peak C was present in control plasma and accounted for some of the small negative inotropic effect of control plasma. The peptide corresponding to peak D had a marked myocardial depressant effect which could account for all the activity of shock plasma. The molecular weight of this peptide was estimated to be 800 to 1000. This peptide is not bradykinin, but appears to be produced by a protease present in shock.ADDITIONAL KEY WORDS kallikrein papillary muscle Trasylol postoligemic shock bradykinin column chromatography toxic factor membrane ultrafiltration eledoisin proteases• Several investigators have reported that there is a substantial increase in the concentration of circulating peptides (1-4) or in proteolytic enzymes (2,5) in the plasma of animals in hemorrhagic shock. However, the role of these peptides in the pathogenesis of hemorrhagic shock is not clear (6)(7)(8)(9). Previous studies have shown that a myocardial depressant factor (MDF) present in the plasma of This investigation was supported by U. S. Public Health Service Crant HE-09924 from the National Heart Institute and by a grant from the American Heart Association. Dr. Lefer is an Established Investigator of the American Heart Association. Mr. Martin is a U. S. Public Health Service research trainee of the National Heart Institute (Crant HE-05661).Received August 16, 1969. Accepted for publication November 9, 1969. cats in postoligemic shock is a peptide having a molecular weight between 500 and 1000 (10). MDF accumulates in the plasma as postoligemic shock progresses, and exerts a depressant effect upon isolated heart muscle (11), upon systemic blood pressure in the intact cat (10), and upon the reticuloendothelial system (12). The purposes of this study were: (a) to determine whether MDF production could be inhibited by a protease inhibitor, and (b) to isolate MDF and determine some aspects of its chemical nature.
Methods
SHOCK PROCEDUREAdult cats of both sexes weighing between 2.4 and 3.1 kg were used for the shock experiments. All cats were isolated for ...